Openbookopenbook
Equity
Dermapharm Holding SE(DMPHF)
USD --+0.00%
Reward51Moderate
Risk44Moderate
📊75%Data
2.3% dividend yield · Revenue down 5% YoY
DMPHF
+0.0 · +0.00%
USD · PINK
Dermapharm Holding SE | Healthcare
Deep Value
Market Cap:2.13Bn
ℹ️
Reward Rating
51
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
44
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on DMPHF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Dermapharm Holding SE?

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

DMPHF · Verdict

Moderate reward · moderate risk

DMPHF stands out on valuation and cash flow, but watch the growth signal.

Based on 88% data coverage

DMPHF · Verdict

What’s working & what to watch

Strengths 3

  • Valuation78/100

    P/E 14.3×

  • Cash flow75/100

    14% free-cash-flow margin

  • Profitability69/100

    10% net margin · 19% ROE

Watchouts 2

  • Growth32/100

    Rev +7.8% CAGR · earnings -18.4%

  • Balance sheet42/100

    Interest covered 3.9×

Model-based scoring. For information only — not financial advice.

What is Dermapharm Holding SE?

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 2.13B, and a P/E ratio of 17.9x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (51)

The scoring profile indicates limited reward potential at this time, with valuation and profitability offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap2.13B
P/E Ratio17.9005
Dividend Yield2.28%
52 Week High42.684
52 Week Low37.5639
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding54M
No. of Employees3,610
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta1.005
CurrencyUSD · Reports in EUR
Websiteir.dermapharm.de
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.